Every day, 1,000 young women and girls get HIV, 4,000 lives are lost to TB, and millions who could be helped suffer from serious mental illnesses. Johnson & Johnson's efforts in tackling these health threats, alongside many others, is why the company has continued to rank among the top three working to expand global access to medicines in low- and middle-income countries according to the Access to Medicine Index (ATMI).
Expanding Access to Our Medicines
Today's Top Reads Close
Did you like reading this story? Click the heart to show your love.
Johnson & Johnson Announces a $50 Million Commitment to Support Frontline Health Workers Battling Covid-19Did you like reading this story? Click the heart to show your love.
What You Need to Know About How Johnson & Johnson's Supply Chain Is Responding to the Covid-19 PandemicDid you like reading this story? Click the heart to show your love.